The Australian Government has established the National Cancer Screening Register (NCSR, or Register) to support delivery of the renewed NCSP and the National Bowel Cancer Screening Program.
When fully implemented, the Register will:
- provide one record for each woman participating in the cervical and bowel screening programs; and
- contain the clinical screening history for every woman who has ever participated in cervical screening from the migration of data from state and territory cervical screening registers. Medicare data will be used to identify women in the eligible age group (25-74 years) who have never screened.
The Register once fully implemented will replace the previous state-based cervical screening registers.
Reporting obligations for pathology laboratories
Under the National Cancer Screening Register Rules 2017 (the Rules), from 1 December 2017 pathology practitioners are required to notify prescribed cervical screening information to the Commonwealth Chief Medical Officer (CMO) through the NCSR within 14 days. Information about the notification requirement is available on the Cancer Screening website
The National Pathology Accreditation Advisory Council (NPAAC) Requirements for laboratories reporting tests for the National Cervical Screening Program require laboratories to compare their HPV positivity rates (batches of at least 2000 HPV tests) to the quarterly national average HPV positivity rate calculated from the NCSR.